A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
Clinical trial NCT06684639 · RECRUITING
Trial details
- NCT number
- NCT06684639
- Sponsor
- The General Hospital of Western Theater Command
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2029-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.